The coronavirus disease-19 (COVID-19) period have dictated a different approach to cardiac interventions at our medical institution. We prioritize emergent care geared toward lesser invasive approaches while minimizing hospitalization duration. This reflects upon coronary and structural/valvular cases altogether. Despite potential criticism of this approach, we believe it is the most appropriate therapeutic strategy for this unique period. Further investigation is needed to examine the external validity of our approach in other medical centers worldwide.
Keywords: COVID-19; heart team; percutaneous coronary interventions; transcatheter aortic valve replacement.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.